Isolation, characterization and Genomic analysis of BUCT627: a lytic bacteriophage targeting Stenotrophomonas maltophilia.

Stenotrophomonas maltophilia BUCT627 bacteriophage genome sequencing sequence analysis

Journal

FEMS microbiology letters
ISSN: 1574-6968
Titre abrégé: FEMS Microbiol Lett
Pays: England
ID NLM: 7705721

Informations de publication

Date de publication:
30 Sep 2024
Historique:
medline: 1 10 2024
pubmed: 1 10 2024
entrez: 30 9 2024
Statut: aheadofprint

Résumé

Stenotrophomonas infections pose significant therapeutic challenges due to escalating resistance to antibiotics and chemotherapeutic agents. Phages offer a potential solution by virtue of their specific bacterial targeting capabilities. In this study, we isolated a new Stenotrophomonas bacteriophage, named BUCT627, from hospital sewage. Phage BUCT627 exhibited a 30-minute latent period and demonstrated a burst size of 46 PFU/cell. Remarkably, this phage displayed robust stability across a wide pH range (pH 3-13) and exhibited resilience under varying thermal conditions. The receptor of phage BUCT627 on S. maltophilia No.826 predominantly consist of surface proteins. The complete genome of phage BUCT627 is a 61 860-bp linear double-stranded DNA molecule with a GC content of 56.3%, and contained 99 open reading frames and two tRNAs. Notably, no antibiotic resistance, toxin, virulence related genes or lysogen-formation gene clusters was identified in BUCT627. Transmission electron microscopy and phylogeny analysis indicated that this phage was a new member within the Siphoviridae family. The results of this study will enhance our understanding of phage diversity and hold promise for the development of alternative therapeutic strategies against Stenotrophomonas maltophilia infections.

Identifiants

pubmed: 39349986
pii: 7797277
doi: 10.1093/femsle/fnae076
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of FEMS.

Auteurs

Chenrui Hou (C)

Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan 030032, China.

Xuexue Wang (X)

Institutes of Biomedical Sciences, Shanxi Provincial Key Laboratory for Medical Molecular Cell Biology, Shanxi University, Taiyuan 030006, China.

Jianguang Guo (J)

Office of Taian Central Blood Station of Shandong Province, Taian 271000, China.

Chunling Qi (C)

Center for Clinical Laboratory, The Affiliated Taian City Central Hospital of Qingdao University , Taian, 271000, China.

Ying Zhang (Y)

Department of Hepatobiliary Surgery, The Affiliated Taian City Central Hospital of Qingdao University, Taian 271000, China.

Yun Chen (Y)

Department of Minimally Invasive Cancer, The Affiliated Taian City Central Hospital of Qingdao University, Taian 271000, China.

Jiao Feng (J)

Institutes of Biomedical Sciences, Shanxi Provincial Key Laboratory for Medical Molecular Cell Biology, Shanxi University, Taiyuan 030006, China.

Bin Zhao (B)

Pediatric Surgery, The Affiliated Taian City Central Hospital of Qingdao University, Taian 271000, China.

Fei Li (F)

Center for Clinical Laboratory, The Affiliated Taian City Central Hospital of Qingdao University , Taian, 271000, China.
Post-doctoral Programme, Shandong Runde Biotechnology Co., Ltd, Taian 271000, China.

Classifications MeSH